HeartService
Financiado
ECG patch and diagnostic service center for efficient and accurate ECG home moni...
Cardiovascular disease (CVD) takes the lives of 17.9 million people every year, representing 31% of all global deaths. Early recognition and detection of CVDs is crucial for a patient’s chance of survival. CVD can be discovered by...
Cardiovascular disease (CVD) takes the lives of 17.9 million people every year, representing 31% of all global deaths. Early recognition and detection of CVDs is crucial for a patient’s chance of survival. CVD can be discovered by prolonged electrocardiogram (ECG) monitoring. Unfortunately, the chance to detect cardiac arrhythmias with the commonly used Holter systems is less than 20%. In addition, the delay between doctor visit and diagnosis is long (2 weeks), due to waiting lists in hospitals and a lack of Holter devices and resources for analysis. There is a need for cost-effective solutions for ECG monitoring to enable efficient and timely screening of patients with suspected heart problems.
Glanum Medical is a Dutch start-up company developing a small ECG monitor integrated in a patch as a ground-breaking solution that will enable early diagnoses of cardiac patients. This novel ECG patch is accurate, affordable and patient friendly as compared to conventional Holter systems. The company launches a supporting diagnostic service center for centralized diagnosis by cardiologists. Glanum Medical will provide the infrastructure for distribution and collection of the ECG patch data analysis. As such, the company empowers medical doctors to offer fast, cost-effective and high-quality ECG-based diagnosis.
Glanum will introduce its ECG patch and diagnostic services in 2019 at the Dutch market as a showcase of their product. The company has the ambition to rapidly scale-up to the EU market and will use the SME Phase 1 grant to identify the optimal business strategy for exploitation of its product and service in different EU countries. The feasibility study includes analysis of EU healthcare systems, reimbursement strategies, stakeholder needs and market acceptance to facilitate large-scale roll-out from 2021.
ver más
Duración del proyecto: 6 meses
Fecha Inicio: 2019-04-15
Fecha Fin: 2019-10-31
Fecha Fin: 2019-10-31
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2019-10-31
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
EIC-SMEInst-2018-2020:
SME instrument
Cerrada
hace 6 años
Presupuesto
El presupuesto total del proyecto asciende a
71K€
Líder del proyecto
GLANUM MEDICAL BV
No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico
TRL
4-5
Perfil tecnológico
TRL
4-5
325.88K€ |
Participante